In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System™)

Vox Sanguinis

Volumn 100, Issue 2, 2011, Pages 247-249

  Chavarin, P ^a   Cognasse, F ^a   Argaud, C ^a   Vidal, M ^a   De Putter, C ^a   Boussoulade, F ^a   Ripaud, C ^b   Acquart, S ^a   Lin, L ^c   Garraud, O ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b Cerus Europe BV   (Netherlands)

^c CERUS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN;

APHERESIS; ARTICLE; BLOOD BUFFY COAT; BLOOD COMPONENT; BLOOD DONOR; CLINICAL ASSESSMENT; IN VITRO STUDY; PH; PHOTOCHEMISTRY; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION;

BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; BLOOD PRESERVATION; DISINFECTION; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; PSORALENS; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 78651329604     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01389.x     Document Type: Article

References (10)

1. Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997; 37:423-35
2. McCullough J, Vesole DH, Benjamin RJ, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004; 104:1534-41
3. Gulliksson H, AuBuchon JP, Cardigan R, et al. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sang 2003; 85:199-205
4. van der Meer PF, Kerkhoffs JL, Curvers J, et al. In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang 2010; 98:517-24
5. Diedrich B, Sandgren P, Jansson B, et al. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94:96-102
6. Cardigan R, Cooke L, Cookson P, et al. Recovery and survival of buffy coat-derived platelets stored for 7 days in plasma or additive solution. Transfusion 2009; 49:86A
7. Deane M, Rivera P, Sawyer L: INTERCEPT platelets treated and stored in SSP+ meet council of Europe standards for in vitro function after 7 days of storage. Transfus Med Hemother 2009; 36:34
8. Stebler C, Paglieroni T, Holland P: Modified PASIII containing magnesium and potassium improves in vitro storage parameters of pathogen-inactivated platelets. Transfusion 2004; 44:66A
9. Osselaer JC, Doyen C, Defoin L, et al. Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use. Transfusion 2009; 49:1412-22
10. Guide to the Preparation, Use and Quality Assurance of Blood Components, 12th edn. Strasbourg, Council of Europe Publishing, 2006